Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: Clinicopathologic characteristics and prognosis

Journal of Breast Cancer

Volumn 14, Issue 4, 2011, Pages 308-313

  Bae, Soo Youn ^a   Choi, Min Young ^b   Cho, Dong Hui ^b   Lee, Jeong Eon ^b   Nam, Seok Jin ^b   Yang, Jung Hyun ^a  

^a Konkuk University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Breast; Invasive ductal carcinoma; Mucinous; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FAMILY HISTORY; FOLLOW UP; GENE OVEREXPRESSION; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; MUCINOUS CARCINOMA; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PROGNOSIS; RISK ASSESSMENT;

EID: 84863067777     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2011.14.4.308     Document Type: Article

References (26)

1. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat 2008; 111:541-7.
2. Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer 1988;61:989-96.
3. Lacroix-Triki M, Suarez PH, MacKay A, Lambros MB, Natrajan R, Savage K, et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 2010;222:282-98.
4. André S, Cunha F, Bernardo M, Meneses e Sousa J, Cortez F, Soares J. Mucinous carcinoma of the breast a pathologic study of 82 cases. J Surg Oncol 1995;58:162-7.
5. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol 1999; 17:1442-8.
6. Louwman MW, Vriezen M, van Beek MW, Nolthenius-Puylaert MC, van der Sangen MJ, Roumen RM, et al. Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 2007;121:127-35.
7. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC The pathology of invasive breast cancer. A syllabus derived from fndings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 1975;36:1-85.
8. Memis A, Ozdemir N, Parildar M, Ustun EE, Erhan Y. Mucinous (colloid) breast cancer: mammographic and US features with histologic correlation. Eur J Radiol 2000;35:39-43.
9. Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Ann Surg Oncol 1998; 5:447-51.
10. Simpson JF Page DL. Prognostic value of histopathology in the breast. Semin Oncol 1992;19:254-62.
11. Rosen PP, Lesser ML, Kinne DW. Breast carcinoma at the extremes of age: a comparison of patients younger than 35 years and older than 75 years. J Surg Oncol 1985;28:90-6.
12. Rasmussen BB, Rose C, Christensen IB. Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol 1987;87:155-60.
13. Silverberg SG, Kay S, Chitale AR, Levitt SH. Colloid carcinoma of the breast. Am J Clin Pathol 1971;55:355-63.
14. Histological typing of breast tumors. Tumori 1982;68:181-98.
15. Fujii H, Anbazhagan R Bornman DM, Garrett ES, Perlman E, Gabrielson E. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast Cancer Res Treat 2002;76:255-60.
16. Ahn SH; Korean Breast Cancer Society. Clinical characteristics of breast cancer patients in Korea in 2000. Arch Surg 2004;139:27-30.
17. Ahn SH, Yoo KY; Korean Breast Cancer Society Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res Treat 2006;99:209-14.
18. Singletary SE, Allred C, Ashley P Bassett LW, Berry D, Bland KI, et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003;83:803-19.
19. Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer 1981;48:299-309.
20. Park S, Koo J, Kim JH, Yang WI, Park BW, Lee KS. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specifed. J Korean Med Sci 2010;25:361-8.
21. Mnami Y, Tsubono Y, Nishino Y, Ohuchi N, Shibuya D, Hisamichi S. The increase of female breast cancer incidence in Japan: emergence of birth cohort effect. Int J Cancer 2004;108:901-6.
22. Vo T, Xing Y, Meric-Bernstam F, Mrza N, Vlastos G, Symmans WF, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas afer lumpectomy. Am J Surg 2007;194: 527-31.
23. Norris HJ, Taylor HB. Prognosis of mucinous (gelatinous) carcinoma of the breast Cancer 1965;18:879-85.
24. Fentiman IS, Mllis RR, Smith P, Ellul JP, Lampejo O. Mucoid breast carcinomas: histology and prognosis. Br J Cancer 1997;75:1061-5.
25. Toikkanen S, Kujari H. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol 1989;20:758-64.
26. Paramo JC, Wilson C, Velarde D, Giraldo J, Poppiti RJ, Mesko TW. Pure mucinous carcinoma of the breast: is axillary staging necessary? Ann Surg Oncol 2002;9:161-4.